drugset / Trial / NCT00887562

Study of Idebenone in the Treatment of Mitochondrial Encephalopathy Lactic Acidosis & Stroke-like Episodes

NCT00887562

Phase 2 Completed 27 enrolled Michio Hirano Santhera Pharmaceuticals · collab
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to compare the efficacy of two (2) different doses of idebenone with that of a placebo over a one month period on cerebral lactate concentration as measured by magnetic resonance spectroscopy.

Timeline

Start
2009-05
Primary completion
2012-07
Completion
2012-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Idebenone Small molecule 900 mg
Subject Idebenone Small molecule 2250 mg

Indications